澳洋健康(002172) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for the third quarter was ¥457,628,364.12, a decrease of 2.57% compared to the same period last year[3] - Net profit attributable to shareholders increased significantly by 533.86% to ¥8,557,819.04 for the quarter[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥2,354,254.97, up 63.23% year-on-year[3] - Total operating revenue decreased to ¥1,360,398,182.64 from ¥1,501,392,158.94, representing a decline of approximately 9.4% year-over-year[18] - Net profit increased to ¥40,715,203.44 compared to ¥39,622,828.72, reflecting a growth of approximately 2.8% year-over-year[18] - The company's investment income improved to ¥1,992,707.08 from a loss of ¥460,456.68, marking a positive turnaround[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,928,841,756.34, a decrease of 5.96% from the previous year[3] - Total assets decreased to ¥1,928,841,756.34 from ¥2,051,047,821.36, a decline of about 6.0%[16] - Total liabilities decreased to ¥1,773,861,055.90 from ¥1,935,817,324.36, a reduction of approximately 8.4%[16] - The company's fixed assets rose to CNY 766,676,307.87 from CNY 668,395,685.45, marking an increase of approximately 14.7%[14] - The company has a goodwill amounting to CNY 10,085,353.67, unchanged from the previous period[14] Equity and Shareholder Information - The owner's equity attributable to shareholders increased by 29.82% to ¥174,636,111.86 compared to the end of the previous year[3] - Total equity increased to ¥154,980,700.44 from ¥115,230,497.00, reflecting a growth of about 34.5%[16] - The number of ordinary shareholders at the end of the reporting period was 58,320[9] Cash Flow and Operating Activities - Cash flow from operating activities showed a net increase of 87.50%, amounting to -¥28,655,423.31 year-to-date[3] - Cash flow from operating activities totaled ¥1,360,151,975.06, down from ¥1,762,781,352.49, a decrease of approximately 22.8% year-over-year[20] - Net cash flow from operating activities was -$28.66 million, a significant improvement from -$229.24 million in the previous period, indicating a positive trend in operational efficiency[21] - Cash paid to employees was approximately $240.80 million, slightly down from $245.26 million, reflecting cost control measures[21] - Cash paid for taxes increased to $43.54 million from $41.73 million, indicating a rise in tax obligations[21] Current Assets and Inventory - The company reported a total current assets of CNY 1,055,512,613.01 as of September 30, 2025, down from CNY 1,128,216,751.49 at the beginning of the period, representing a decrease of approximately 6.4%[14] - Cash and cash equivalents decreased to CNY 460,072,797.69 from CNY 521,489,938.85, reflecting a decline of about 11.8%[14] - Accounts receivable increased to CNY 320,242,539.93 from CNY 291,583,598.00, indicating a growth of approximately 9.8%[14] - Inventory decreased to CNY 133,597,757.54 from CNY 149,474,811.92, showing a reduction of about 10.6%[14] Investment and Financing Activities - The company reported a significant increase in investment income by 532.77% year-on-year due to gains from the disposal of subsidiaries[8] - Cash inflow from financing activities totaled $1.11 billion, down from $1.40 billion, primarily due to a decrease in borrowings[21] - The net cash flow from financing activities was $15.20 million, a decrease from $109.57 million, suggesting tighter cash management strategies[21] - Total cash outflow from investing activities was $29.54 million, compared to $76.76 million in the prior period, reflecting a reduction in capital expenditures[21] Audit and Reporting - The company has not yet audited its third-quarter financial report, which may affect the reliability of the reported figures[24]